451 results on '"Downes, Susan M."'
Search Results
2. Central serous chorioretinopathy: An evidence-based treatment guideline
3. A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
4. An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma
5. Quantification of Fundus Autofluorescence Features in a Molecularly Characterized Cohort of More Than 3000 Inherited Retinal Disease Patients from the United Kingdom
6. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes
7. Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
8. Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy.
9. “Genetic and clinical findings in an ethnically diverse retinitis pigmentosa cohort associated with pathogenic variants in EYS”
10. Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
11. Targeted next generation sequencing and family survey enable correct genetic diagnosis in CRX associated macular dystrophy – a case report
12. Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial
13. Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy
14. Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
15. Central serous chorioretinopathy: Towards an evidence-based treatment guideline
16. Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
17. RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4
18. Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort study.
19. The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
20. Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy
21. Retinal Angiomatous Proliferation in a Patient with Retinitis Pigmentosa
22. New Imaging Technology for Simultaneous Multiwavelength-UWF Fundus Fluorescein Angiography and Indocyanine Green Angiography With Navigated Central and Peripheral SS-OCT
23. Understanding the impact of genetic testing for inherited retinal dystrophy
24. Hydroxychloroquine hitting the headlines—retinal considerations
25. Handheld laser devices and laser-induced retinopathy (LIR) in children: an overview of the literature
26. Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage
27. A Carrier Female Manifesting an Unusual X-Linked Retinoschisis Phenotype Associated with the Pathogenic Variant c.266delA, p.(Tyr89LeufsTer37) in RS1, and Skewed X-Inactivation
28. Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
29. Intraretinal Microvascular Abnormalities and Venous Beading Have Different Genetic Profiles in Caucasian Patients with Non-Proliferative Diabetic Retinopathy
30. Can artificial intelligence accelerate the diagnosis of inherited retinal diseases? Protocol for a data-only retrospective cohort study (Eye2Gene)
31. The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
32. Unravelling the genetics of inherited retinal dystrophies: Past, present and future
33. Sudden Gross Visual Deterioration: Importance of Examining the Whole Eye
34. INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
35. Functional Defects in Color Vision in Patients With Choroideremia
36. Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers.
37. Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers
38. A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
39. Spontaneous Resolution of Chronic Central Serous Chorioretinopathy: “Fuji Sign”
40. Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes
41. The Natural History of Leber Congenital Amaurosis and Cone–Rod Dystrophy Associated with Variants in the GUCY2D Gene
42. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
43. The positive impact of e-mail referrals on access to specialist macula services
44. Sickle Cell Retinopathy and Hemoglobinopathies
45. Sleep, light and the eye.
46. Rapid Quantification of the Binocular Visual Field for Clinical Trials: Performance of a Modified Esterman Supra-Threshold Test Implemented with the Open Perimetry Interface
47. EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
48. Ocular Toxicity of Mitogen-Activated Protein Kinase Inhibitors
49. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations
50. Whole genome sequencing in a Knobloch syndrome family confirms the molecular diagnosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.